OKTO Ophtho Reports Successful Exhibition at 2003 ASCRS
COSTA MESA, California – 17 April 2003–
OKTO Ophtho, the premier developer and distributor of specialty
technologies for eye surgery, reported a successful exhibition at
the 2003 American Society of Cataract and Refractive Surgeons (ASCRS)
meeting in San Francisco, California.
OKTO’s state-of-the-art, multi-media exhibit displayed its
core technologies for eye surgery: AmbioDry™ Amniotic Membrane
Allografts and SutureGroove™ Gold Eyelid Weight Implants
AmbioDry Allografts, processed tissue grafts derived from human
placenta, are employed by eye surgeons for the treatment of a variety
of ocular surface disorders and defects. AmbioDry Allografts are
processed in the United States in alliance with Celgene Corporation.
In comparison to competitive tissue options, the advantages of
the AmbioDry are vast: decellularized, sterile tissue matrix; shelf-life
storage; prepares in minutes for surgery; substrate-free; consistent
SutureGroove Gold Eyelid Weights are employed by oculoplastic surgeons
for the treatment of lagophthalmos. The proprietary SutureGroove
technology, licensed by OKTO from AMI, incorporates suture fixation
channels within the gold weight for perfected implant placement
and improved patient cosmesis.
“We are extremely excited with and pleased by the enthusiastic
reception both the AmbioDry and SutureGroove technologies received
at this critical meeting. We are further rewarded with the assurance
that we are offering the ophthalmologist clear benefits in safety,
logistics and ease of use”, stated Erich Ziegler President
of OKTO Ophtho.
Founded in 2000, OKTO Ophtho develops and commercializes specialized,
leading-edge surgical technologies for eye surgery. OKTO’s
purpose is to develop surgical solutions that improve the quality
of life for patients, elevate the performance and productivity of
eye care professionals, and lower costs to the provider.
OKTO currently holds leadership positions with surgical devices
for oculoplastic surgeries and bio-implant technologies for ocular